Top Clinical Trials companies in Hong Kong by Return on Capital Employed (ROCE)
Hong Kong
# |
Name |
Return on Capital Employed (ROCE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
6.74%
|
Dec. 31, 2023 | USD 2.68 | -1.44% |
|
Hong Kong |
|
| 2 |
4.28%
|
Dec. 31, 2023 | USD 0.22 | -1.18% |
|
Hong Kong |
|
| 3 |
1.94%
|
Dec. 31, 2023 | USD 0.16 | -3.21% |
|
Hong Kong |
|
| 4 |
-25.94%
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
|
| 5 |
-122.89%
|
Dec. 31, 2023 | USD 0.37 | 4.31% |
|
Hong Kong |
Frequently Asked Questions
-
Which Clinical Trials company in Hong Kong has the highest Return on Capital Employed (ROCE) ?
The Clinical Trials company in Hong Kong with the highest Return on Capital Employed (ROCE) is HUTCHMED (China) Limited (HKSE: 0013.HK) at 6.74%.
-
Which Clinical Trials company in Hong Kong has the lowest Return on Capital Employed (ROCE) ?
The Clinical Trials company in Hong Kong with the lowest Return on Capital Employed (ROCE) is Sirnaomics Ltd. (HKSE: 2257.HK) at -122.89%.
-
What are the top 10 Clinical Trials companies in Hong Kong by Return on Capital Employed (ROCE) ?
The top 10 Clinical Trials companies in Hong Kong by Return on Capital Employed (ROCE) are HUTCHMED (China) Limited, Frontage Holdings Corporation, Lee's Pharmaceutical Holdings Limited, Prenetics Global Limited and Sirnaomics Ltd..
-
What are the bottom 10 Clinical Trials companies in Hong Kong by Return on Capital Employed (ROCE) ?
The bottom 10 Clinical Trials companies in Hong Kong by Return on Capital Employed (ROCE) are Sirnaomics Ltd., Prenetics Global Limited, Lee's Pharmaceutical Holdings Limited, Frontage Holdings Corporation and HUTCHMED (China) Limited.
